RMD logo

ResMed (RMD) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$238.36 M
+$10.47 M+4.59%

June 30, 2024


Summary


Performance

RMD Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRMDbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$521.94 M
+$95.58 M+22.42%

December 31, 2024


Summary


Performance

RMD Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRMDbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

RMD Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.6%0.0%
3 y3 years-19.3%+168.4%
5 y5 years+62.0%+155.7%

RMD Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-19.3%+4.6%at high+168.4%
5 y5-year-48.5%+62.0%at high+168.4%
alltimeall time-73.7%>+9999.0%-48.5%>+9999.0%

ResMed Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
-
$521.94 M(+22.4%)
Sep 2024
-
$426.36 M(+78.9%)
Jun 2024
$238.36 M(+4.6%)
$238.36 M(+0.2%)
Mar 2024
-
$237.91 M(+13.2%)
Dec 2023
-
$210.25 M(+0.5%)
Sep 2023
-
$209.10 M(-8.2%)
Jun 2023
$227.89 M(-16.7%)
$227.89 M(-0.0%)
Mar 2023
-
$227.89 M(-10.0%)
Dec 2022
-
$253.20 M(+22.2%)
Sep 2022
-
$207.16 M(-24.3%)
Jun 2022
$273.71 M(-7.3%)
$273.71 M(+35.7%)
Mar 2022
-
$201.77 M(+3.8%)
Dec 2021
-
$194.48 M(-29.6%)
Sep 2021
-
$276.15 M(-6.5%)
Jun 2021
$295.28 M(-36.2%)
$295.28 M(+28.0%)
Mar 2021
-
$230.63 M(-9.9%)
Dec 2020
-
$255.87 M(-39.3%)
Sep 2020
-
$421.41 M(-9.0%)
Jun 2020
$463.16 M(+214.8%)
$463.16 M(+31.3%)
Mar 2020
-
$352.86 M(+72.9%)
Dec 2019
-
$204.09 M(+18.6%)
Sep 2019
-
$172.15 M(+17.0%)
Jun 2019
$147.13 M(-22.0%)
$147.13 M(+0.4%)
Mar 2019
-
$146.51 M(-2.0%)
Dec 2018
-
$149.47 M(-35.1%)
Sep 2018
-
$230.19 M(+22.0%)
Jun 2018
$188.70 M(-77.0%)
$188.70 M(-73.2%)
Mar 2018
-
$704.28 M(-18.0%)
Dec 2017
-
$858.90 M(+5.9%)
Sep 2017
-
$811.10 M(-1.3%)
Jun 2017
$821.93 M(+12.4%)
$821.93 M(-0.6%)
Mar 2017
-
$827.31 M(+5.0%)
Dec 2016
-
$788.15 M(+0.8%)
Sep 2016
-
$781.66 M(+6.9%)
Jun 2016
$731.43 M(+2.0%)
$731.43 M(+1.8%)
Mar 2016
-
$718.50 M(+9.1%)
Dec 2015
-
$658.80 M(-19.9%)
Sep 2015
-
$822.05 M(+14.6%)
Jun 2015
$717.25 M(-20.8%)
$717.25 M(-17.2%)
Mar 2015
-
$866.33 M(-1.6%)
Dec 2014
-
$880.70 M(-0.1%)
Sep 2014
-
$881.69 M(-2.7%)
Jun 2014
$905.73 M(+3.4%)
$905.73 M(-3.5%)
Mar 2014
-
$938.56 M(-3.5%)
Dec 2013
-
$972.67 M(-0.4%)
Sep 2013
-
$976.57 M(+11.5%)
Jun 2013
$876.05 M(+8.2%)
$876.05 M(-13.5%)
Mar 2013
-
$1.01 B(+5.7%)
Dec 2012
-
$958.28 M(+7.6%)
Sep 2012
-
$890.63 M(+10.0%)
Jun 2012
$809.54 M(+10.1%)
$809.54 M(+4.3%)
Mar 2012
-
$776.07 M(+7.3%)
Dec 2011
-
$723.23 M(+18.6%)
Sep 2011
-
$610.06 M(-17.0%)
Jun 2011
$735.27 M(+50.4%)
$735.27 M(+9.5%)
Mar 2011
-
$671.70 M(+9.0%)
Dec 2010
-
$616.20 M(+14.1%)
Sep 2010
-
$540.00 M(+10.5%)
Jun 2010
$488.78 M
$488.78 M(-6.2%)
DateAnnualQuarterly
Mar 2010
-
$520.94 M(+15.4%)
Dec 2009
-
$451.43 M(-5.5%)
Sep 2009
-
$477.82 M(+15.0%)
Jun 2009
$415.65 M(+29.5%)
$415.65 M(+27.1%)
Mar 2009
-
$327.07 M(+2.1%)
Dec 2008
-
$320.49 M(+6.1%)
Sep 2008
-
$302.07 M(-5.9%)
Jun 2008
$321.08 M(+24.5%)
$321.08 M(+4.4%)
Mar 2008
-
$307.49 M(+10.4%)
Dec 2007
-
$278.50 M(+10.8%)
Sep 2007
-
$251.31 M(-2.5%)
Jun 2007
$257.79 M(+17.4%)
$257.79 M(+7.4%)
Mar 2007
-
$240.11 M(+3.2%)
Dec 2006
-
$232.67 M(+15.7%)
Sep 2006
-
$201.16 M(-8.4%)
Jun 2006
$219.54 M(+54.4%)
$219.54 M(+32.1%)
Mar 2006
-
$166.16 M(+18.4%)
Dec 2005
-
$140.28 M(+8.1%)
Sep 2005
-
$129.73 M(-8.8%)
Jun 2005
$142.19 M(+10.3%)
$142.19 M(+4.0%)
Mar 2005
-
$136.70 M(-4.5%)
Dec 2004
-
$143.07 M(+1.0%)
Sep 2004
-
$141.62 M(+9.9%)
Jun 2004
$128.91 M(+12.6%)
$128.91 M(+12.5%)
Mar 2004
-
$114.57 M(+6.6%)
Dec 2003
-
$107.46 M(+2.7%)
Sep 2003
-
$104.68 M(-8.6%)
Jun 2003
$114.49 M(+57.1%)
$114.49 M(+22.2%)
Mar 2003
-
$93.72 M(+13.6%)
Dec 2002
-
$82.47 M(+12.1%)
Sep 2002
-
$73.57 M(+1.0%)
Jun 2002
$72.86 M(+81.5%)
$72.86 M(+29.6%)
Mar 2002
-
$56.23 M(-12.2%)
Dec 2001
-
$64.05 M(+6.0%)
Sep 2001
-
$60.44 M(+50.6%)
Jun 2001
$40.14 M(+119.9%)
$40.14 M(+63.4%)
Mar 2001
-
$24.57 M(+45.8%)
Dec 2000
-
$16.86 M(+23.8%)
Sep 2000
-
$13.62 M(-25.4%)
Jun 2000
$18.25 M(+64.4%)
$18.25 M(+11.6%)
Mar 2000
-
$16.36 M(+42.2%)
Dec 1999
-
$11.50 M(+6.5%)
Sep 1999
-
$10.80 M(-2.7%)
Jun 1999
$11.10 M(-28.4%)
$11.10 M(+2.8%)
Mar 1999
-
$10.80 M(-20.6%)
Dec 1998
-
$13.60 M(-17.6%)
Sep 1998
-
$16.50 M(+6.5%)
Jun 1998
$15.50 M(+70.3%)
$15.50 M(+31.4%)
Mar 1998
-
$11.80 M(+55.3%)
Dec 1997
-
$7.60 M(-43.3%)
Sep 1997
-
$13.40 M(+47.3%)
Jun 1997
$9.10 M(+65.5%)
$9.10 M(+5.8%)
Mar 1997
-
$8.60 M(0.0%)
Dec 1996
-
$8.60 M(+32.3%)
Sep 1996
-
$6.50 M(+18.2%)
Jun 1996
$5.50 M(+66.7%)
$5.50 M(+37.5%)
Mar 1996
-
$4.00 M(+21.2%)
Jun 1995
$3.30 M(-10.8%)
$3.30 M(-10.8%)
Jun 1994
$3.70 M(+117.6%)
$3.70 M(+117.6%)
Jun 1993
$1.70 M
$1.70 M

FAQ

  • What is ResMed annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for ResMed?
  • What is ResMed annual cash & cash equivalents year-on-year change?
  • What is ResMed quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for ResMed?
  • What is ResMed quarterly cash and cash equivalents year-on-year change?

What is ResMed annual cash & cash equivalents?

The current annual cash & cash equivalents of RMD is $238.36 M

What is the all time high annual cash & cash equivalents for ResMed?

ResMed all-time high annual cash & cash equivalents is $905.73 M

What is ResMed annual cash & cash equivalents year-on-year change?

Over the past year, RMD annual cash & cash equivalents has changed by +$10.47 M (+4.59%)

What is ResMed quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of RMD is $521.94 M

What is the all time high quarterly cash and cash equivalents for ResMed?

ResMed all-time high quarterly cash and cash equivalents is $1.01 B

What is ResMed quarterly cash and cash equivalents year-on-year change?

Over the past year, RMD quarterly cash and cash equivalents has changed by $0.00 (0.00%)